YB-1-based oncolytic virotherapy in combination with CD47 blockade enhances phagocytosis of pediatric sarcoma cellsAnna Josefine von Ofen(München Klinik Schwabing), Sebastian Johannes Schober(München Klinik Schwabing)Frontiers in OncologyJanuary 31, 202410.3389/fonc.2024.1304374Cited by 1SaveCiteExport RISWatch citationsRelated PapersTCR-transgenic T cells and YB-1-based oncolytic virotherapy improve survival in a preclinical Ewing sarcoma xenograft mouse model|Frontiers in Immunology|2024|5